BR112022003895A2 - Sistema e método de entrega de múltiplos fármacos - Google Patents
Sistema e método de entrega de múltiplos fármacosInfo
- Publication number
- BR112022003895A2 BR112022003895A2 BR112022003895A BR112022003895A BR112022003895A2 BR 112022003895 A2 BR112022003895 A2 BR 112022003895A2 BR 112022003895 A BR112022003895 A BR 112022003895A BR 112022003895 A BR112022003895 A BR 112022003895A BR 112022003895 A2 BR112022003895 A2 BR 112022003895A2
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- delivery system
- drug
- drug delivery
- interior
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/074—Filling capsules; Related operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962893567P | 2019-08-29 | 2019-08-29 | |
| US201962893573P | 2019-08-29 | 2019-08-29 | |
| US202062981180P | 2020-02-25 | 2020-02-25 | |
| US202063022823P | 2020-05-11 | 2020-05-11 | |
| PCT/US2020/048107 WO2021041608A1 (en) | 2019-08-29 | 2020-08-27 | System and method of multi-drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022003895A2 true BR112022003895A2 (pt) | 2022-05-24 |
Family
ID=74683538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022003895A BR112022003895A2 (pt) | 2019-08-29 | 2020-08-27 | Sistema e método de entrega de múltiplos fármacos |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4021420A4 (de) |
| JP (1) | JP2022546496A (de) |
| CN (1) | CN114650810A (de) |
| AU (1) | AU2020336093A1 (de) |
| BR (1) | BR112022003895A2 (de) |
| CA (1) | CA3152734A1 (de) |
| IL (1) | IL290961A (de) |
| MX (1) | MX2022002526A (de) |
| WO (1) | WO2021041608A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115989023A (zh) * | 2020-08-25 | 2023-04-18 | 艾伯维公司 | 多药物递送的系统和方法 |
| US11273128B1 (en) * | 2021-04-15 | 2022-03-15 | Sandoz Ag | Elagolix formulation |
| CN116648239A (zh) * | 2021-08-26 | 2023-08-25 | 宁德时代新能源科技股份有限公司 | 液囊、电池单体、电池和用电装置 |
| CN113876728B (zh) * | 2021-11-17 | 2022-12-13 | 南京唯创远医药科技有限公司 | 一种噁拉戈利冻干片及其制备方法 |
| EP4279075B1 (de) * | 2022-05-12 | 2024-07-10 | Zaklady Farmaceutyczne Polpharma S.A. | Pharmazeutische zusammensetzung enthaltend elagolix |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
| US20080075772A1 (en) * | 2006-04-13 | 2008-03-27 | Lawrence Solomon | Pharmaceutical compositions having novel scoring patterns and methods of using those compositions |
| WO2010014502A1 (en) * | 2008-07-31 | 2010-02-04 | Aptapharma, Inc. | Functionally coated breakable tablets |
| KR101861307B1 (ko) * | 2011-10-13 | 2018-07-06 | 한미약품 주식회사 | 정제를 포함하는 경질 캡슐 복합 제형 |
| EP3384930A1 (de) * | 2013-03-15 | 2018-10-10 | AbbVie Inc. | Verfahren zur behandlung schwerer menstruationsblutungen |
| US9456987B2 (en) * | 2013-04-03 | 2016-10-04 | Binutra, Inc. | Capsule with internal diaphragm |
| AU2017316583A1 (en) * | 2016-08-23 | 2019-03-28 | Mylan Inc. | Child resistant medication packaging |
| TW201912157A (zh) * | 2017-08-18 | 2019-04-01 | 美商艾伯維有限公司 | 治療子宮內膜異位症、子宮纖維瘤、多囊性卵巢症候群及子宮腺肌症之固體醫藥調配物 |
-
2020
- 2020-08-27 CN CN202080074708.5A patent/CN114650810A/zh active Pending
- 2020-08-27 JP JP2022513623A patent/JP2022546496A/ja active Pending
- 2020-08-27 MX MX2022002526A patent/MX2022002526A/es unknown
- 2020-08-27 EP EP20857394.9A patent/EP4021420A4/de active Pending
- 2020-08-27 AU AU2020336093A patent/AU2020336093A1/en not_active Abandoned
- 2020-08-27 CA CA3152734A patent/CA3152734A1/en active Pending
- 2020-08-27 WO PCT/US2020/048107 patent/WO2021041608A1/en active Application Filing
- 2020-08-27 BR BR112022003895A patent/BR112022003895A2/pt unknown
-
2022
- 2022-02-27 IL IL290961A patent/IL290961A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4021420A1 (de) | 2022-07-06 |
| WO2021041608A1 (en) | 2021-03-04 |
| CA3152734A1 (en) | 2021-03-04 |
| IL290961A (en) | 2022-04-01 |
| MX2022002526A (es) | 2022-06-23 |
| JP2022546496A (ja) | 2022-11-04 |
| CN114650810A (zh) | 2022-06-21 |
| EP4021420A4 (de) | 2023-11-22 |
| AU2020336093A1 (en) | 2022-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022003895A2 (pt) | Sistema e método de entrega de múltiplos fármacos | |
| BR112018076601A2 (pt) | formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação | |
| CY1124052T1 (el) | Δισκιο διασπειρομενο στο στομα περιεχον οιστετρολη | |
| CY1124104T1 (el) | Δισκιο διασπειρομενο στο στομα περιεχον οιστετρολη | |
| CL2017003320A1 (es) | Formulaciones farmacéuticas que contienen tenofovir y emtricitabina | |
| BR112018077541A2 (pt) | formulações orais gastrorretentivas e usos das mesmas | |
| BR112019015904A2 (pt) | Sistemas e métodos para a fabricação de comprimidos, incluindo comprimidos farmacêuticos | |
| BR112017001442A2 (pt) | ?rolhas e métodos de liofilização e vedação de um medicamento? | |
| MX2019003099A (es) | Composicion farmaceutica. | |
| BR112017014793A2 (pt) | regime de dosagem para antagonistas de madcam | |
| BR112019024566A2 (pt) | inibidores de pirazol magl | |
| EP4233902A3 (de) | Behandlung einer krankheit des gastrointestinalen traktus mit einem integrin-hemmer | |
| ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
| MA50189A (fr) | Formulations pharmaceutiques d'oligomère cyclique et d'abiratérone et procédés de formation et d'administration de celles-ci | |
| EA201700019A1 (ru) | Высокочистый оритаванцин и способ его получения | |
| EP3541943A4 (de) | P8-protein exprimierender und sekretierender mikroorganismus zur verabreichung eines arzneimittels zur behandlung von gastrointestinaler erkrankung sowie pharmazeutische zusammensetzung zur vorbeugung oder behandlung von gastrointestinaler erkrankung damit | |
| BR112022005659A2 (pt) | Parâmetros de medição associados à administração de fármacos e dispositivos de administração de fármacos que incorpora os mesmos | |
| BR112019001130A2 (pt) | uso de lactama e composição farmacêutica | |
| IL284132A (en) | A pharmaceutical compound, a method for its preparation and its use as a medicinal substance | |
| IL281217A (en) | Pharmaceutical preparation for controlled release of weak acid drugs and its uses | |
| EP4044192A4 (de) | Verfahren, programm, vorrichtung und system zur unterstützung der bestimmung von mindestens einer darreichungsform und der dosierung eines arzneimittels | |
| WO2016005740A3 (en) | A masking package | |
| CY1122232T1 (el) | Ενωση ιμιδαζοδιαζεπινης | |
| CL2017000026A1 (es) | Formas de dosificación farmacéutica | |
| PH12016502591B1 (en) | Pharmaceutical for treating dizziness having different causes |